EAM Global Investors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-61,390
Closed -$5.76M 107
2023
Q2
$5.76M Sell
61,390
-8,052
-12% -$628K 1.69% 6
2023
Q1
$4.71M Buy
+69,442
New +$4.46M 1.32% 28

Other funds holding EXAS

EAM Global Investors's EXAS Position: Q3 2023 in Review

EAM Global Investors sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 61,390 shares — an estimated $5.76M sold.

EAM Global Investors first reported a position in EXAS in Q1 2023 and held it in 2 quarters. The position peaked at $5.76M in Q2 2023. 624 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • EAM Global Investors reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • EAM Global Investors sold 61,390 Exact Sciences shares in Q3 2023, an estimated $5.76M.
  • EAM Global Investors first reported a position in Exact Sciences in Q1 2023 and held it in 2 quarters.
  • EAM Global Investors's Exact Sciences position peaked at $5.76M in Q2 2023.
  • 624 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on EAM Global Investors's 13F filing for Q3 2023, filed 13 Nov 2023.